Katsuyoshi Suzuki Selected Research

Katsuyoshi Suzuki Research Topics

5	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2023 - 04/2015
5	Glaucoma 12/2022 - 01/2015
3	Ocular Hypertension (Glaucoma, Suspect) 01/2023 - 06/2018
2	Inflammation (Inflammations) 01/2023 - 04/2005
2	Cicatrix (Scar) 01/2015 - 06/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Schizophrenia (Dementia Praecox) 11/2022
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021
1	Keratitis 08/2015
1	Proliferative Vitreoretinopathy 04/2014
1	Uveitis 01/2012
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 01/2012
1	Pancreatitis 03/2008
1	Infections 03/2008

3	Latanoprost (Xalatan)FDA Link 02/2019 - 04/2015
3	tafluprostIBA 02/2019 - 08/2015
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2023 - 08/2015
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 12/2022 - 11/2021
2	brinzolamide (Azopt)FDA Link 12/2022 - 11/2021
2	Timolol (Blocadren)FDA LinkGeneric 02/2019 - 06/2018
2	CollagenIBA 01/2015 - 04/2014
1	Ketamine FDA LinkGeneric 11/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2022
1	Glutamic Acid (Glutamate)FDA Link 11/2022
1	stiripentolIBA 01/2021
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 08/2015
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2014
1	Retinal Pigments (Pigments, Visual)IBA 04/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	biapenem (L 627)IBA 03/2008
1	Imipenem FDA Link 03/2008
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2008
1	Taurocholic Acid (Sodium Taurocholate)IBA 03/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2005